Persistent residual inflammatory risk at 1 month after contemporary PCI: rationale for routine hsCRP reassessment and dual-target therapy - Quiz - MDSpire

Persistent residual inflammatory risk at 1 month after contemporary PCI: rationale for routine hsCRP reassessment and dual-target therapy

  • By

  • Xinwang Gong

  • Chang Zhou

  • Yutao Wu

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Related Content